Clinical Trials in Maryland

Showing 9961-9980 of 17,687 trials

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

NCT02815709

The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy.

Acute Pain

Trevena Inc.418 participantsStarted May 2016

Phoenix, Arizona, United States • Anaheim, California, United States • Pasadena, California, United States +4 more locations

COMPLETEDPhase 317 miles

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

NCT00014222

RATIONALE: 1. . To compare the effects on breast cancer of three different combinations of drugs which are commonly used to treat this disease. 2. . It is not yet known which treatment regimen is most effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.

Breast Cancer

NCIC Clinical Trials Group2,104 participantsStarted Dec 2000

Fort Smith, Arkansas, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +75 more locations

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Find Trials by Condition in Maryland

Losartan to Reverse Sickle Nephropathy

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Virtual Reality for Pain Management in Advanced Heart Failure

Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017

EVOLVE Short DAPT Study

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

A Study of ARRY-520 in Patients With Advanced Cancer

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses

SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib